Antiretroviral Therapy News

  • FDA Panel Recommends Gilead's Quad for HIV A U.S. Food and Drug Administration panel of outside experts has recommended the use of Gilead Sciences Inc's Quad pill for untreated HIV patients.
  • FDA Report on Gilead's Quad Focuses on Kidney Safety Gilead Science Inc's Quad pill appears to be effective at controlling HIV infection but could lead to kidney problems, a U.S. Food and Drug Administration staff report said on Wednesday.
 

Antiretroviral Therapy Perspectives

 

Antiretroviral Therapy Journal Articles

 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.